NTGN Insider Trading Activity and SEC Form 4 Filings
NTGN insider trading summary
No open-market insider purchases or sales of Neon Therapeutics, Inc. (NTGN) have been reported on SEC Form 4 in the past 12 months.
Latest NTGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 24, 2020 | Access Industries Holdings LLC | 10% Owner | Sell | $185K (84,286 @ $2.19) |
| Mar 24, 2020 | Len Blavatnik | Insider | Sell | $259K (117,400 @ $2.20) |
| Mar 24, 2020 | Access Industries Holdings LLC | 10% Owner | Sell | $259K (117,400 @ $2.20) |
| Mar 24, 2020 | Access Industries, LLC | Insider | Sell | $185K (84,286 @ $2.19) |
| Mar 24, 2020 | Access Industries, LLC | Insider | Sell | $259K (117,400 @ $2.20) |
| Mar 24, 2020 | Len Blavatnik | Insider | Sell | $185K (84,286 @ $2.19) |
| Mar 24, 2020 | Clal Biotechnology Industries Ltd. | Insider | Sell | $185K (84,286 @ $2.19) |
| Mar 24, 2020 | Access Industries Management, LLC | Insider | Sell | $259K (117,400 @ $2.20) |
| Mar 24, 2020 | Clal Biotechnology Industries Ltd. | Insider | Sell | $259K (117,400 @ $2.20) |
| Mar 24, 2020 | Access Industries Management, LLC | Insider | Sell | $185K (84,286 @ $2.19) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.